Menzel Garry E
Director at ADAPY; President and CEO at TCR2 THERAPEUTICS INC.
- Sold, on record
- $145k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jul 10, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ADAPYAdaptimmune Therapeutics PLCDirector
- TCR2 THERAPEUTICS INC.President and CEO
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- TCR2 THERAPEUTICS INC.82,187 shares
- ADAPY47,702 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale TCR2 THERAPEUTICS INC.Plan not statedDec 2, 2022 2022
Sold 8,408 shares at $1.39 ($12k)
Menzel Garry E, President & CEO
Sold 3.8% of holdings ($307k position)212,650 shares leftFirst sale on recordFiling
- 2 Form 4 sale TCR2 THERAPEUTICS INC.Plan not statedDec 6, 2022 +4 days
Sold 23,416 shares at $1.36 ($32k)
Menzel Garry E, President and CEO
Sold 11% of holdings ($289k position)189,234 shares leftFiling
- 3 Form 4 sale TCR2 THERAPEUTICS INC.Plan not statedDec 8, 2022 +2 days
Sold 18,425 shares at $1.26 ($23k)
Menzel Garry E, President and CEO
Sold 9.7% of holdings ($239k position)170,809 shares leftFiling
- 4 Form 4 sale TCR2 THERAPEUTICS INC.Plan not statedDec 13, 2022 +5 days
Sold 31,938 shares at $1.10 ($35k)
Menzel Garry E, President and CEO
Sold 18.7% of holdings ($187k position)138,871 shares left1.7x usual sizeFiling
- 5 Form 4 sale ADAPYUnusualJul 10, 2023 +209 days
Sold 47,702 shares at $0.91 ($43k)
Menzel Garry E, Director
No 10b5-1 planSold 38.9% of holdings ($112k position)75,056 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2023 | Jul 10, 2023 | ADAPY | Director | Form 4 sale | 47,702 | $43k | 38.9% | Unusual | SEC |
| Dec 13, 2022 | Dec 13, 2022 | TCR2 THERAPEUTICS INC. | President and CEO | Form 4 sale | 31,938 | $35k | 18.7% | Plan not stated | SEC |
| Dec 8, 2022 | Dec 9, 2022 | TCR2 THERAPEUTICS INC. | President and CEO | Form 4 sale | 18,425 | $23k | 9.7% | Plan not stated | SEC |
| Dec 6, 2022 | Dec 7, 2022 | TCR2 THERAPEUTICS INC. | President and CEO | Form 4 sale | 23,416 | $32k | 11.0% | Plan not stated | SEC |
| Dec 2, 2022 | Dec 5, 2022 | TCR2 THERAPEUTICS INC. | President & CEO | Form 4 sale | 8,408 | $12k | 3.8% | Plan not stated | SEC |